Choate Investment Advisors Boosts Position in CME Group Inc. (NASDAQ:CME)

Choate Investment Advisors boosted its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 8.2% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,418 shares of the financial services provider’s stock after buying an additional 107 shares during the period. Choate Investment Advisors’ holdings in CME Group were worth $329,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Lake Street Advisors Group LLC grew its position in CME Group by 108.7% in the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock valued at $2,949,000 after acquiring an additional 6,453 shares in the last quarter. Meyer Handelman Co. acquired a new stake in CME Group in the fourth quarter valued at approximately $6,144,000. Spire Wealth Management grew its position in CME Group by 37.4% in the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock valued at $307,000 after acquiring an additional 359 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc grew its position in CME Group by 19.3% in the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock valued at $75,730,000 after acquiring an additional 52,862 shares in the last quarter. Finally, Unified Investment Management acquired a new stake in CME Group in the fourth quarter valued at approximately $503,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the subject of several recent research reports. Piper Sandler increased their price objective on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Morgan Stanley raised their price target on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 19th. Raymond James raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target for the company in a research report on Monday, March 10th. Oppenheimer raised their price target on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. Finally, JPMorgan Chase & Co. raised their price target on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research report on Thursday, February 13th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average price target of $238.93.

View Our Latest Stock Analysis on CME Group

Insider Buying and Selling at CME Group

In related news, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the sale, the director now directly owns 21,873 shares in the company, valued at $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the sale, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 27,076 shares of company stock worth $6,871,496. 0.30% of the stock is owned by insiders.

CME Group Stock Performance

CME stock opened at $263.58 on Tuesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The stock has a market capitalization of $94.98 billion, a price-to-earnings ratio of 27.26, a PEG ratio of 6.76 and a beta of 0.53. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $264.95. The stock’s fifty day moving average is $243.56 and its two-hundred day moving average is $232.93.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.90%. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio (DPR) is presently 51.71%.

CME Group declared that its board has initiated a share repurchase program on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.